The Insurance Regulatory and Development Authority of India (IRDAI) has approved the acquisition of Magma General Insurance by Patanjali Ayurved and the DS Group for ₹4,500 crore, clearing the final regulatory hurdle for the FMCG giant’s entry into the general insurance business. Patanjali Ayurved will acquire a 73.56 per cent controlling stake, while the DS Group, maker of Rajnigandha, will take a 24.50 per cent stake in the insurer. In a parallel move, the regulator has also granted a licence to ProTec General Insurance, a joint venture between the M Pallonji Group and Divya Sehgal of the private equity firm True North.
The Deal at a Glance
The transaction was first announced to stock exchanges on 12 March 2025, when the boards of the selling shareholders approved a share purchase agreement (SPA) with Patanjali Ayurved and the DS Group. The approval letter from IRDAI came only on 28 July 2026, nearly 16 months after the deal was announced, making it the final regulatory clearance required.
The shares are being sold by Sanoti Properties LLP, a holding entity in which Adar Poonawalla, Chairman of the Serum Institute of India, holds a 90 per cent stake, with the remaining 10 per cent held by Rising Sun Holdings. Sanoti Properties held a 72.4 per cent stake in Magma General Insurance before the transaction. Two other selling shareholders, Celica Developers and Jaguar Advisory Services, complete the sale. Combined, the buyers will control about 98 per cent of the insurer.
Under the terms of the IRDAI approval, Patanjali Ayurved becomes the promoter of Magma General Insurance, while the DS Group joins as a co-investor. Patanjali is expected to continue infusing capital to support the insurer’s growth and solvency. The regulator’s approval is valid for three months, within which the transaction must be completed.
The Numbers Behind the Deal
| Particular | Detail |
|---|---|
| Deal value | ₹4,500 crore |
| Patanjali Ayurved stake | 73.56% |
| DS Group stake | 24.50% |
| Combined stake | About 98% |
| Seller | Sanoti Properties LLP, with Celica Developers and Jaguar Advisory Services |
| Sanoti’s pre-deal holding | 72.4% |
| Deal announced | 12 March 2025 |
| IRDAI approval | 28 July 2026 |
Patanjali and the DS Group: The Buyers
Patanjali Ayurved is an Indian fast-moving consumer goods (FMCG) company headquartered in Haridwar, Uttarakhand, and closely associated with yoga teacher Baba Ramdev and Managing Director Acharya Balkrishna. The company began as a small pharmacy in Haridwar in 1997 and was formally incorporated in 2006. It has since grown into one of India’s largest consumer goods firms, manufacturing ayurvedic medicines, packaged foods, personal care products and household goods under the Patanjali brand.
Patanjali’s most valuable asset for the insurance business is its distribution network. Its products are available at approximately 2 lakh retail counters across the country, including national retail chains and more than 250 Patanjali Mega Stores. Industry observers expect the company to use this retail footprint to sell insurance in semi-urban and rural India, where its brand has deep recognition.
The DS Group, formally the Dharampal Satyapal Group, is a diversified conglomerate founded in 1929 in Chandni Chowk, New Delhi, and now headquartered in Noida. It is best known for Rajnigandha, the country’s leading pan masala brand, and also runs food and beverage, tobacco and hospitality businesses through brands such as Catch spices, Pass Pass and Baba products. The group has been expanding from consumer products into financial services, and its partnership in the insurer makes it a co-investor alongside Patanjali.
Magma General Insurance: A Well-Travelled Journey
Magma General Insurance has had a series of owners since it was set up as a joint venture between Indian finance company Magma Fincorp and German insurer HDI Global SE, part of the German Talanx Group. It operated for years as Magma HDI General Insurance.
The ownership began to change in February 2021, when Adar Poonawalla, through his firm Rising Sun Holdings, acquired a controlling stake in Magma Fincorp, the non-banking financial company (NBFC), for around ₹3,456 crore. Magma Fincorp was later renamed Poonawalla Fincorp. Over the following years, the insurer was rechristened Magma General Insurance as the German partner exited and the business was consolidated under the Poonawalla group.
Adar Poonawalla is the Chairman of the Serum Institute of India, the world’s largest vaccine manufacturer by volume, which produces the Covishield vaccine. He is part of the wealthy Poonawalla family based in Pune. His decision to sell Magma General Insurance aligns with his focus on strengthening the Poonawalla group’s core non-banking financial businesses.
How Magma Has Performed
Magma General Insurance offers more than 70 products across motor, health, property and other general insurance lines. Its business has grown faster than the industry. The insurer’s gross direct premium grew at a compound annual growth rate of 22 per cent between FY21 and FY25, against a general insurance industry average of 10 per cent over the same period.
The company returned to profitability in FY25 after a loss-making FY24. It reported a net profit of ₹1 crore in FY25, against a loss of ₹141 crore in FY24, and a net profit of ₹27 crore in the first nine months of FY26. Its solvency ratio stood at 1.81 times as of 31 December 2025, comfortably above the regulatory minimum of 1.50 times, leaving excess capital of about ₹268 crore. The insurer’s gross written premium rose to ₹3,615.48 crore in FY26 from ₹3,334.4 crore in FY25.
Why Buy a Licence When You Can Buy an Insurer?
The acquisition is a strategic shortcut. Instead of applying for a fresh insurance licence and building an insurance company from scratch, a time-consuming process that involves meeting strict capital and experience requirements, Patanjali is buying a fully licensed, operational insurer with an existing product suite, an established network of agents, corporate clients and automobile manufacturers, and a solvency position above the regulatory floor.
This route is becoming increasingly popular among large Indian business groups. In a two-week window in March 2025, India’s insurance sector saw deals worth more than ₹38,000 crore. The largest was the Bajaj Group’s buyout of German insurer Allianz’s 26 per cent stake in their two joint venture insurers for ₹24,180 crore. In the same period, IndusInd International Holdings completed its acquisition of Reliance Capital, the parent of two insurers, while Prudential of the UK tied up with the HCL Group for a standalone health insurer.
There is a clear logic to the trend. The Insurance Regulatory and Development Authority of India (IRDAI) has a stated vision of insurance for all by 2047, and the market is underpenetrated, leaving a large runway for growth. New entrants with established consumer distribution networks see insurance as a natural adjacent revenue stream, one where they can sell to the same customers who already buy their products.
ProTec General Insurance: A Parallel New Entrant
The IRDAI’s decision to grant a Certificate of Registration to ProTec General Insurance Limited was announced after the regulator’s 137th Authority meeting on 28 July 2026. The approval was the regulator’s fourth insurance licence in calendar year 2026, after Kiwi General Insurance, Prudential HCL Health Insurance and Allianz Jio Reinsurance.
ProTec is promoted by the M Pallonji Group in partnership with Divya Sehgal, a partner at the Mumbai-based private equity firm True North. The M Pallonji Group, built by the Mistry family and led by brothers Mehli Mistry and Pheroze Mistry, is best known for logistics, dredging, barging, shipping and industrial contracting through its flagship firm M Pallonji & Co. The company was incorporated in 1950, though the group traces its business roots to the Pallonji family’s earlier ventures. Company records show Mehli Mistry, Pheroze Mistry and Divya Sehgal as directors of the new venture, along with Aditya Sharma, a former chief distribution officer at Bajaj General Insurance.
The venture had earlier planned for the M Pallonji Group to hold a 51 per cent majority stake, with additional capital from Federal Bank and several family offices, before the final shareholding structure was settled. The group had applied to IRDAI for the licence in March 2025, and received the first-stage R1 approval in April 2026 and the R2 approval in July 2026 before the final licence.
ProTec joins a non-life sector that already has more than 25 general insurers, including four public sector insurers such as the New India Assurance and National Insurance, and private players such as ICICI Lombard, Bajaj General and SBI General. New entrants are aiming at a market that India’s insurance regulator wants to expand dramatically.
A Sector Opening Up: The Regulatory Context
Both developments come against the backdrop of a major opening up of India’s insurance sector. Parliament passed the Sabka Bima Sabki Raksha (SBSR) Act in December 2025, formally the Insurance Laws (Amendment) Act, 2025, which amended three laws: the Insurance Act, 1938, the Life Insurance Corporation Act, 1956 and the Insurance Regulatory and Development Authority Act, 1999.
The most significant change is the increase in the foreign direct investment (FDI) limit in Indian insurance companies from 74 per cent to 100 per cent of paid-up equity capital, under the automatic route. The Act also reduced the net-owned fund requirement for foreign reinsurance branches from ₹5,000 crore to ₹1,000 crore, raised the threshold for prior IRDAI approval of share transfers from 1 per cent to 5 per cent of paid-up capital, and set up the Policyholders’ Education and Protection Fund to promote awareness and protect policyholders.
Following the amendment, one life insurer and one general insurer have already raised foreign shareholding beyond the earlier 74 per cent cap to full ownership. IRDAI has described this as a signal of greater investor confidence that could bring higher capital inflows into the sector.
The Insurance Regulatory and Development Authority of India (IRDAI) itself is the statutory regulator for the insurance industry, established under the IRDA Act, 1999 and headquartered in Hyderabad. It is charged with protecting policyholder interests and ensuring the orderly growth of the insurance sector. At its 137th Authority meeting, the regulator also approved a package of reforms covering liberalised investment norms, streamlined capital infusion and restructuring, stronger actuarial oversight, perpetual registration for intermediaries in place of periodic renewals, and a framework for imposing penalties.
What This Means for India’s Insurance Market
India’s general insurance sector is projected to grow to about ₹5.4 lakh crore in gross written premium by 2030, according to market estimates, with non-life premiums expected to grow at a compound annual rate of roughly 10 per cent between 2026 and 2030. Yet the sector remains underpenetrated: non-life insurance penetration stands at around 1 per cent of GDP, well below the global average, which points to the structural growth opportunity underpinning the recent deal activity.
For Patanjali
The acquisition marks Patanjali’s first major foray into financial services. Its value proposition is distribution. With products already sold through about 2 lakh retail outlets, the company is positioned to push insurance into semi-urban and rural India, where rural insurance literacy remains low and where a trusted consumer brand can help bridge the awareness gap. Under IRDAI’s terms, Patanjali will act as promoter and is expected to inject growth capital into the insurer.
For the Sector
The deal reinforces a broader pattern of large Indian business groups entering insurance through acquisition rather than fresh licensing. This route lets conglomerates deploy their existing brands, balance sheets and distribution strengths into a growing, underpenetrated sector. Combined with the 100 per cent FDI opening, the entry of new promoters and investors is expected to intensify competition, broaden product choice and, the regulator hopes, push insurance coverage closer to its stated goal of insurance for all by 2047.
The Strategic Read
Insurance is a capital-intensive, long-gestation business, and consumer brands entering it bring both money and reach. Patanjali’s move, in particular, is being watched closely because it tests whether an ayurveda and FMCG brand can convert its formidable rural distribution into a mass-market insurance franchise. The answer will depend on how quickly the insurer’s products, pricing and claim experience can win the trust of first-time insurance buyers in smaller towns and villages.
Key Takeaways
- The IRDAI approved the ₹4,500 crore acquisition of Magma General Insurance by Patanjali Ayurved (73.56%) and the DS Group (24.50%) on 28 July 2026, clearing the final regulatory hurdle for the deal first announced in March 2025.
- The sellers were Sanoti Properties LLP, a holding company in which Adar Poonawalla holds 90 per cent, along with Celica Developers and Jaguar Advisory Services; the buyers will control about 98 per cent of the insurer.
- Magma General Insurance, formerly Magma HDI General Insurance, was consolidated under the Poonawalla group after Adar Poonawalla acquired a controlling stake in Magma Fincorp in February 2021 for around ₹3,456 crore.
- The insurer offers more than 70 products across motor, health and property lines, reported ₹3,615.48 crore in gross written premium in FY26, and had a solvency ratio of 1.81 times as of 31 December 2025, above the regulatory minimum of 1.50 times.
- The IRDAI separately granted a licence to ProTec General Insurance, a joint venture between the M Pallonji Group and Divya Sehgal of True North, its fourth insurance licence approval in 2026.
- The moves follow the Sabka Bima Sabki Raksha (SBSR) Act of December 2025, which raised the FDI limit in insurance from 74% to 100%, as India’s regulator pursues its goal of insurance for all by 2047.
